Xvivo Perfusion AB (publ)
SSE:XVIVO.ST
282 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Xvivo Perfusion AB (publ) |
Symbool | XVIVO.ST |
Munteenheid | SEK |
Prijs | 282 |
Beurswaarde | 8,882,859,000 |
Dividendpercentage | 0% |
52-weken bereik | 205.5 - 343.5 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Christoffer Rosenblad |
Website | https://www.xvivoperfusion.com |
An error occurred while fetching data.
Over Xvivo Perfusion AB (publ)
Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO System (XPS), an integrated off-the-shelf
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)